Hanover Bancorp is thinly followed, so the analyst picture is unusually narrow. Two named, dated targets can be verified. Piper Sandler's Adam Kroll rates the stock Overweight and raised his target to $29 in late October 2026, up from $26.50 earlier in the year. Stephens & Co. maintains an Equal-Weight (Hold) rating with a $23 target set earlier in 2026. Raymond James initiated coverage in August 2026 with a Market Perform rating but no published price target.
Averaging the two verifiable targets — $29 and $23 — produces a mean of $26, the central target used here. The resulting range of $23 to $29 is unusually wide relative to the stock's price, which reflects genuine disagreement: one firm sees meaningful upside from a profit recovery, while the other sees the shares as fairly valued. Some aggregators report a slightly higher average near $26.50 drawing on additional data, but the $26 figure reflects only the individually verifiable targets. Investors should treat this as a thin, divergent set of views rather than a tight consensus. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Hanover Bancorp shares recently traded around $21.37, near the lower portion of a 52-week range spanning roughly $20 to $28. Reaching the $26 target would require an advance of approximately 21.7%, a substantial move for a bank that trades only about 20,000 to 40,000 shares daily and can swing sharply on modest volume.
The path toward that level would most plausibly run through continued improvement in profitability. The company reported quarterly EPS (earnings per share) of $0.60, up from $0.47 a year earlier, roughly matching consensus. Continued loan growth, stable credit costs, and a benign net interest margin environment would support the case. Even so, $26 still sits below the stock's 52-week high near $28, meaning the target represents a partial recovery rather than a new record.
Several fundamentals point in a favorable direction. Earnings per share have risen year over year, reflecting loan growth and effective cost management. The board has authorized a share repurchase program, which can support the stock by reducing the share count. The bank also pays a dividend, with a yield near 1.8%, providing modest income for holders. As a community lender, Hanover Bancorp can also benefit if regional economic activity in the New York metro area remains firm and if credit losses stay contained. The Overweight rating from Piper Sandler signals that at least one analyst sees the earnings power as underappreciated.
The risks are equally tangible. Community banks with portfolios weighted toward multi-family and commercial mortgages carry meaningful commercial real estate exposure, and any deterioration in property values or borrower stress could pressure credit costs and investor sentiment. Net interest margins can compress if deposit costs remain elevated even as loan yields fall. As a micro-cap with limited analyst coverage and thin liquidity, the stock is susceptible to outsized moves and can trade below intrinsic value for extended periods. Insider selling activity has also been noted by some data providers, a factor that can weigh on near-term confidence.
Technically, the shares sit closer to support than resistance. The $20 area represents both a psychological level and the vicinity of the 52-week low, while the prior peak near $28 serves as the primary resistance zone. A move toward $26 would require the stock to reclaim the middle of its range and approach the upper band set by that earlier high. Long-term, the stock has been range-bound rather than in a clear uptrend, meaning the $26 target aligns with a recovery scenario rather than a breakout to new highs.
Analyst price targets generally reflect a roughly 12-month outlook, though no single horizon applies uniformly across the two firms. Investors should watch the next quarterly earnings report, expected around late January 2027, for guidance on loan growth, net interest margin, and credit quality. Equally important are any analyst revisions, changes in Federal Reserve interest-rate policy that affect funding costs and lending spreads, and updates on commercial real estate conditions in the bank's markets. Repurchase activity and insider transactions are additional signals worth following.
For traders who prefer a systematic approach, Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals as market conditions, technical behavior, and AI-driven analysis evolve. The tool is designed to help users discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual screening allows. Whether or not Hanover Bancorp approaches the $26 target, automated signals can offer a useful second lens for timing decisions and managing risk across a broader watchlist. In my view, this kind of AI assistance has become a practical addition to traditional research when following thinly covered names like this one.
The question of whether Hanover Bancorp can reach $26 is best understood as a measured recovery scenario, not a consensus forecast. The $26 central target — the mean of Piper Sandler's $29 and Stephens & Co.'s $23 — implies a roughly 22% advance from the recent price near $21.37, a substantial but attainable move. The bull case rests on improving earnings, buybacks, and a stable credit backdrop, while the bear case centers on commercial real estate risk, margin pressure, and thin liquidity. With analyst views split and coverage sparse, the outcome will likely hinge on the next several quarters of loan performance and profitability. Investors should monitor earnings, credit trends, and rate developments rather than treating any single price target as a guarantee.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Indicator for HNVR moved into overbought territory on November 20, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for HNVR just turned positive on November 13, 2026. Looking at past instances where HNVR's MACD turned positive, the stock continued to rise in 21 of 46 cases over the following month. The odds of a continued upward trend are 46%.
Following a +0.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where HNVR advanced for three days, in 89 of 176 cases, the price rose further within the following month. The odds of a continued upward trend are 51%.
HNVR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HNVR as a result. In 29 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 32%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HNVR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
The Aroon Indicator for HNVR entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.779) is normal, around the industry mean (1.265). P/E Ratio (17.062) is within average values for comparable stocks, (13.523). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.194). Dividend Yield (0.018) settles around the average of (0.036) among similar stocks. P/S Ratio (2.546) is also within normal values, averaging (3.751).
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. HNVR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 63 (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HNVR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 59, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry RegionalBanks